Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
Medical science monitor : international medical journal of experimental and clinical research 2018 Oct 24 7057-7071.
Xu Bin, Zhu Ya, Tang Yu, Zhang Zhenyong, Wen Qiaxi
Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies.
Experimental and therapeutic medicine 2012 Nov 4 (5): 938-948.
Leng Wei-Dong, Zeng Xian-Tao, Chen Yong-Ji, Duan Xiao-Li, Niu Yu-Ming, Long Rong-Pei, Luo Zhi-Xi